| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |